A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH

✍ Scribed by Miroslava Macova; Jaroslav Pavel; Juan M. Saavedra

• Book ID: 113503953
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 924 KB
• Volume: 1250
• Category: Article
• ISSN: 0006-8993
• DOI: 10.1016/j.brainres.2008.11.006